IRIS PubliCatt

Chiusolo, Patrizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.408
EU - Europa 5.952
AS - Asia 1.949
OC - Oceania 140
AF - Africa 82
SA - Sud America 59
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.294
DE - Germania 2.007
SE - Svezia 1.037
CN - Cina 913
IT - Italia 889
SG - Singapore 413
UA - Ucraina 386
GB - Regno Unito 315
IE - Irlanda 312
FR - Francia 297
ID - Indonesia 237
FI - Finlandia 149
RU - Federazione Russa 148
IN - India 145
PL - Polonia 126
AU - Australia 122
CA - Canada 89
TR - Turchia 63
CI - Costa d'Avorio 54
NL - Olanda 37
BE - Belgio 36
BR - Brasile 29
JP - Giappone 28
ES - Italia 27
CZ - Repubblica Ceca 26
HK - Hong Kong 24
IR - Iran 24
AT - Austria 20
RO - Romania 20
VN - Vietnam 19
NZ - Nuova Zelanda 18
MX - Messico 17
HU - Ungheria 16
CH - Svizzera 15
TH - Thailandia 13
KR - Corea 12
PT - Portogallo 12
NO - Norvegia 11
AR - Argentina 10
CL - Cile 10
SA - Arabia Saudita 10
DZ - Algeria 9
GR - Grecia 9
HR - Croazia 8
IL - Israele 8
EG - Egitto 7
SK - Slovacchia (Repubblica Slovacca) 7
BG - Bulgaria 6
CO - Colombia 5
EE - Estonia 5
LB - Libano 5
MY - Malesia 5
NP - Nepal 5
RS - Serbia 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 4
BZ - Belize 4
DK - Danimarca 4
EU - Europa 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
GH - Ghana 3
MD - Moldavia 3
MK - Macedonia 3
PE - Perù 3
QA - Qatar 3
ZA - Sudafrica 3
BD - Bangladesh 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
IQ - Iraq 2
IS - Islanda 2
JO - Giordania 2
LI - Liechtenstein 2
MA - Marocco 2
UY - Uruguay 2
KE - Kenya 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
MM - Myanmar 1
MT - Malta 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PR - Porto Rico 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 14.597
Salva come PNG Salva come JPEG
Città #
Chandler 1.057
Ashburn 447
Dublin 305
Jacksonville 294
Singapore 273
Dearborn 243
Jakarta 227
San Mateo 227
Nanjing 178
Ann Arbor 169
Milan 166
Houston 162
Wilmington 158
Beijing 144
Rome 126
Woodbridge 116
New York 114
Nürnberg 114
Fairfield 113
Boston 112
Moscow 109
Redwood City 106
Warsaw 106
Seattle 101
Los Angeles 100
Lancaster 91
Cattolica 89
Nanchang 84
Marseille 81
Princeton 81
Bremen 71
Lawrence 68
Chicago 55
Munich 55
Abidjan 54
Florence 53
Redmond 53
Izmir 49
Kunming 46
Boardman 44
Helsinki 42
Cambridge 33
Tianjin 33
Brussels 32
Norwalk 32
Shenyang 32
Shanghai 30
Guangzhou 29
Pune 29
Leawood 28
Hangzhou 27
Changsha 26
Hefei 26
San Francisco 26
Mountain View 25
Zhengzhou 25
Sydney 24
Hebei 23
Melbourne 23
Phoenix 23
Portland 23
Washington 23
Adelaide 22
Auburn Hills 22
Brno 22
London 22
Jiaxing 21
Toronto 20
Brisbane 19
Hong Kong 19
Lappeenranta 19
Philadelphia 18
Augusta 17
Brooklyn 16
Hanoi 16
San Diego 16
University Park 16
Buffalo 12
Santa Clara 12
Amsterdam 10
Bangkok 10
Changchun 10
Falls Church 10
Fremont 10
Lanzhou 10
Padova 10
Pittsburgh 10
Seoul 10
Vienna 10
Atlanta 9
Bologna 9
Cincinnati 9
Cleveland 9
Hermosillo 9
Kansas City 9
Kyoto 9
Mumbai 9
North Hollywood 9
Nuremberg 9
Auckland 8
Totale 7.362
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.227
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 351
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: An open-label, multicentre, randomised, phase 3 trial 306
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 304
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 225
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 165
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 148
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 142
Correlation between paraproteinaemia and viral reactivation after allo-SCT 139
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 135
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 134
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 132
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 131
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 131
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 129
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 126
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 125
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 122
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 122
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 119
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia 118
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 114
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 114
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 114
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 113
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 112
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 112
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 109
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 106
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 105
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 104
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 103
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 103
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 102
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 102
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 101
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 101
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 101
Hyperleukocytosis and leukostasis: management of a medical emergency 100
Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia. 99
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 99
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 99
Hyperleukocytosis and leukostasis: management of a medical emergency 99
Work related acute leukemia and mucor mycosis in a boat-builder 98
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 97
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 97
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 95
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 94
Neurologic improvement after peripheral blood stem cell transplantation in poems 94
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 93
Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study 93
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease 92
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 90
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 89
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 89
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 87
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 86
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 85
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 85
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial 83
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 82
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 82
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 81
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 80
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 79
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 78
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy 76
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 76
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 75
UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen 74
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study 71
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 71
Changes in protein serum levels during stem cell transplantation 70
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 70
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 68
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 67
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 67
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 66
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 65
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 65
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 64
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 63
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 63
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 63
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo 62
Unrelated cord blood transplantation and post-transplant cyclophosphamide 62
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 62
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 61
Unrelated cord blood transplantation and post-transplant cyclophosphamide 61
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 61
Mononuclear cell collection for extracorporeal photopheresis: Concentrate characteristics for off-line UV-A irradiation procedure 60
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 59
Cytokine profile of autologous platelet-derived eye drops in patients with ocular chronic graft-versus-host disease 58
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo 58
ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- And Long-term Outcomes 58
Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome 57
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 57
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 57
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 56
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 56
Totale 12.051
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.671
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.444 0 0 0 147 203 236 199 96 122 166 156 119
2020/20211.252 81 116 81 96 111 101 114 32 151 60 265 44
2021/20221.549 150 91 43 70 104 39 35 219 90 127 261 320
2022/20233.213 435 436 243 475 226 378 182 241 316 89 134 58
2023/20242.666 84 450 125 172 150 302 162 115 105 259 367 375
2024/20251.148 358 271 442 77 0 0 0 0 0 0 0 0
Totale 14.938